# Ultrasound Guided Octreotide LAR Injection in Acromegaly

> **NCT00552071** · PHASE4 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** Octreotide LAR 30 MG Injection

## Key facts

- **NCT ID:** NCT00552071
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00552071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00552071, "Ultrasound Guided Octreotide LAR Injection in Acromegaly". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00552071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*